These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. Younes M; Ertan A; Lechago LV; Somoano J; Lechago J Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):303-5. PubMed ID: 9149888 [TBL] [Abstract][Full Text] [Related]
26. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218 [TBL] [Abstract][Full Text] [Related]
27. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Nakagawa H; Wang TC; Zukerberg L; Odze R; Togawa K; May GH; Wilson J; Rustgi AK Oncogene; 1997 Mar; 14(10):1185-90. PubMed ID: 9121767 [TBL] [Abstract][Full Text] [Related]
29. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144 [TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Shinozaki H; Ozawa S; Ando N; Tsuruta H; Terada M; Ueda M; Kitajima M Clin Cancer Res; 1996 Jul; 2(7):1155-61. PubMed ID: 9816282 [TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus]. Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305 [TBL] [Abstract][Full Text] [Related]
33. Genomic alterations in malignant transformation of Barrett's esophagus. Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006 [TBL] [Abstract][Full Text] [Related]
35. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Yacoub L; Goldman H; Odze RD Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315 [TBL] [Abstract][Full Text] [Related]
37. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma. Wang XW; Gao HJ; Fang DC J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760 [TBL] [Abstract][Full Text] [Related]